Cancer Research Meeting Calendar  Sign up for Cancer Research eTOC's
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 50, 7159-7165, November 15, 1990]
© 1990 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ruggiero, R. A.
Right arrow Articles by Pasqualini, C. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ruggiero, R. A.
Right arrow Articles by Pasqualini, C. D.

Correlation between Seric Antitumor Activity and Concomitant Resistance in Mice Bearing Nonimmunogenic Tumors1

Raúl A. Ruggiero2,3,, Oscar D. Bustuoabad3, Paula Cramer4, R. Daniel Bonfil3 and Christiane Dosne Pasqualini3

División Medicina Experimental, Instituto de Investigaciones Hematológicas, Academia Nacional de Medicina, Las Heras 3092, 1425 Buenos Aires, Argentina

Serum from mice bearing five weakly immunogenic or nonimmunogenic tumors inducing concomitant resistance exhibited a growth-inhibitory activity on in vitro proliferation of the tumor cells. This activity was proportional to the intensity of concomitant resistance and correlated with the capacity to restrain metastatic development. It was not attributable to cytotoxic antibodies, was relatively nonspecific, and operated through a cytostatic and reversible mechanism. All attempts to transfer antitumor resistance in vivo by serum inoculation have failed, but this could be attained by parabiosis. Physical and chemical serum treatments suggest that heat-, acid-, and alkali-resistant peptide(s) with molecular weights ranging from 1000 to 3000 could account for this inhibitory effect.

1 This study was supported by national grants from CONICET, FUNDALEU, Fundación Antorchas, and Fundación Alberto J. Roemmers.

2 To whom requests for reprints should be addressed.

3 Member of Research Caceer, CONICET (Consejo Nacional de Investigaciones Cientificias y Técnicas).

4 Fellow of FUNDALEU (Fundación para Combatir la Leucemia).

Received 1/18/90. Accepted 7/30/90.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1990 by the American Association for Cancer Research.